1EAX

Crystal structure of MTSP1 (matriptase)

Structural Biology Knowledgebase: 1EAX SBKB.org


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.3 Å
  • R-Value Free: 0.193
  • R-Value Work: 0.184

Literature

Macromolecules
Sequence Display for 1EAX

Classification: HYDROLASE

Total Structure Weight: 26680.15

Macromolecule Entities
Molecule Chains Length Organism Details
SUPPRESSOR OF TUMORIGENICITY 14 A 241 Homo sapiens EC#: 3.4.21.109 IUBMB
Fragment: CATALYTIC RESIDUES 615-855
Gene Name(s): ST14 Gene View PRSS14 SNC19 TADG15
Metabolic Pathways
Maps:       
Reactions:
ESCHER  BiGG

Small Molecules
Ligands 2 Unique
ID Chains Name / Formula / InChI Key 2D Diagram 3D Interactions
BEN
Query on BEN

A BENZAMIDINE
C7 H8 N2
PXXJHWLDUBFPOL-UHFFFAOYSA-N
Ligand Explorer NGL
 
Binding Pocket (JSmol)
 
Electron Density (JSmol)
SO4
Query on SO4

A SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
Ligand Explorer NGL
 
Binding Pocket (JSmol)
 
Electron Density (JSmol)
External Ligand Annotations
ID Binding Affinity (Sequence Identity %)
BEN Ki: 400000 nM (100) BindingDB

N/A in BindingMoad
N/A in PDBbind

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.3 Å
  • R-Value Free: 0.193
  • R-Value Work: 0.184
  • Space Group: C 2 2 2

Unit Cell:

Length (Å) Angle (°)
a = 66.92 α = 90.00
b = 141.60 β = 90.00
c = 51.94 γ = 90.00

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History

Deposition Data

  • Deposited Date: 2001-07-17
  • Released Date: 2002-01-28
  • Deposition author(s): Friedrich, R., Bode, W.

Revision History

  • 2015-04-15
    Type: Refinement description | Details: REMARK 3
  • 2015-04-15
    Type: Non-polymer description | Details: FORMUL
  • 2015-04-15
    Type: Biological assembly | Details: REMARK 350
  • 2015-04-15
    Type: Secondary structure | Details: SHEET
  • 2015-04-15
    Type: Citation | Details: JRNL
  • 2015-04-15
    Type: Other | Details: REMARK 525
  • 2015-04-15
    Type: Version format compliance | Details: REMARK 4